Kevin Cannon

2.2k total citations
12 papers, 243 citations indexed

About

Kevin Cannon is a scholar working on Epidemiology, Molecular Biology and Internal Medicine. According to data from OpenAlex, Kevin Cannon has authored 12 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 3 papers in Molecular Biology and 2 papers in Internal Medicine. Recurrent topics in Kevin Cannon's work include Influenza Virus Research Studies (4 papers), Respiratory viral infections research (4 papers) and Pneumonia and Respiratory Infections (3 papers). Kevin Cannon is often cited by papers focused on Influenza Virus Research Studies (4 papers), Respiratory viral infections research (4 papers) and Pneumonia and Respiratory Infections (3 papers). Kevin Cannon collaborates with scholars based in United States, Canada and United Kingdom. Kevin Cannon's co-authors include Jeffrey Yao, Daniel A. Scott, Wendy Watson, William C. Gruber, Yahong Peng, Ingrid L. Scully, Robert W. Frenck, Vani Sundaraiyer, Eduardo Forleo‐Neto and Xia Xu and has published in prestigious journals such as New England Journal of Medicine, Brain and Clinical Infectious Diseases.

In The Last Decade

Kevin Cannon

11 papers receiving 235 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Cannon United States 6 181 33 31 28 24 12 243
Brian Ramjattan United States 7 262 1.4× 30 0.9× 15 0.5× 20 0.7× 26 1.1× 8 354
JN Zuckerman United Kingdom 5 63 0.3× 11 0.3× 19 0.6× 14 0.5× 9 0.4× 12 117
Andrea Schaeffer United States 6 76 0.4× 4 0.1× 42 1.4× 54 1.9× 9 0.4× 11 225
John Barthelow Classen United States 8 65 0.4× 8 0.2× 60 1.9× 21 0.8× 40 1.7× 19 246
M Knuf Germany 7 264 1.5× 205 6.2× 36 1.2× 21 0.8× 22 0.9× 10 320
S. C. Arya India 8 68 0.4× 9 0.3× 27 0.9× 35 1.3× 5 0.2× 35 184
Tracy Fletcher United Kingdom 6 121 0.7× 76 2.3× 17 0.5× 102 3.6× 29 1.2× 9 261
F. Fily France 6 55 0.3× 14 0.4× 49 1.6× 11 0.4× 2 0.1× 10 183
К. О. Миронов Russia 6 67 0.4× 37 1.1× 29 0.9× 30 1.1× 2 0.1× 64 142
Jehad Abdalla United States 7 40 0.2× 8 0.2× 60 1.9× 20 0.7× 4 0.2× 14 163

Countries citing papers authored by Kevin Cannon

Since Specialization
Citations

This map shows the geographic impact of Kevin Cannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Cannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Cannon more than expected).

Fields of papers citing papers by Kevin Cannon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Cannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Cannon. The network helps show where Kevin Cannon may publish in the future.

Co-authorship network of co-authors of Kevin Cannon

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Cannon. A scholar is included among the top collaborators of Kevin Cannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Cannon. Kevin Cannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Fitzpatrick, David, Lisa A. Jackson, Graham Crowther, et al.. (2025). Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine. New England Journal of Medicine. 393(20). 2001–2011. 3 indexed citations
2.
3.
4.
Cannon, Kevin, José F. Cardona, Kari Yacisin, et al.. (2023). Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial. Vaccine. 41(13). 2137–2146. 12 indexed citations
5.
6.
Essink, Brandon, Charu Sabharwal, Kevin Cannon, et al.. (2021). Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years. Clinical Infectious Diseases. 75(3). 390–398. 94 indexed citations
7.
Bart, Stephan, et al.. (2016). Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study. Human Vaccines & Immunotherapeutics. 12(9). 2278–2288. 39 indexed citations
8.
9.
Piazza, Gregory, Venkatesh Mani, Michael Grosso, et al.. (2014). Abstract 12074: A Randomized, Open-Label, Multicenter Study of the Efficacy and Safety of Edoxaban Monotherapy versus Low-Molecular Weight Heparin/Warfarin in Patients With Symptomatic Deep Vein Thrombosis - Edoxaban Thrombus Reduction Imaging Study (eTRIS). 130. 4 indexed citations
10.
Yao, Jeffrey, P. James B. Dyck, Kevin Cannon, & Jürgen Ludwig. (1984). LIPID ABNORMALITIES OF XANTHOMATOUS NERVES. Brain. 107(2). 597–603. 2 indexed citations
11.
Yao, Jeffrey & Kevin Cannon. (1983). [14C]Acetate metabolism in the peripheral nervous system. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 753(3). 331–338. 24 indexed citations
12.
Yao, Jeffrey, Kevin Cannon, Ralph T. Holman, & P. James B. Dyck. (1983). Effects of polyunsaturated fatty acid diets on plasma lipids of patients with adrenomultineuronal degeneration, hepatosplenomegaly and fatty acid derangement. Journal of the Neurological Sciences. 62(1-3). 67–75. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Ramjattan Breakdown of academic impact, for papers by JN Zuckerman Breakdown of academic impact, for papers by Andrea Schaeffer Breakdown of academic impact, for papers by John Barthelow Classen Breakdown of academic impact, for papers by M Knuf Breakdown of academic impact, for papers by S. C. Arya Breakdown of academic impact, for papers by Tracy Fletcher Breakdown of academic impact, for papers by F. Fily Breakdown of academic impact, for papers by К. О. Миронов Breakdown of academic impact, for papers by Jehad Abdalla
Rankless by CCL
2026